Patent Cooperation Treaty: Evaluating the Benefits and Risks, Obtaining International Patent Protection

With more than 25 years of experience in biotechnology patent prosecution and counseling, Ms. McNeill offers intellectual property strategy, new application preparation, patent prosecution (US and foreign), preparation and negotiation of IP transactions, USPTO contentious practice, and the full scope of counseling services to clients of various sizes. She has earned a reputation for excellence in her field, having been recognized as an IP Star by both Managing Intellectual Property and LMG Life Sciences and ranked with an AV Preeminent® Peer Review Rating from Martindale-Hubbell. ® Ms. McNeill  has worked with biotech start-ups, research foundations, universities, and pharmaceutical companies, ranging from early-stage to publicly-traded companies. She has managed and directed the US and international patent portfolios for US clients and has overseen the US patent portfolio for international clients in Europe and Asia. Ms. McNeill has also expertly resolved material errors made by others in transactions with the US Patent and Trademark Office, in applications under the PCT, or in foreign patent prosecution, including filing errors and errors in the payment of maintenance or annuity fees. She also has experience in litigation and USPTO contentious proceedings. 

Mr. Nørgaard counsels on all areas of life science and medical technology including anything from genetics and molecular biology to drugs, diagnostics, analytical equipment, medical equipment, and greentech. He counsels on IPR strategy, IPR organization and management of companies, business development, license agreements, freedom-to-operate, validity of patents, oppositions and appeals before the EPO (European Patent Office), in addition to drafting and prosecution of patent applications. He also serves as a technical judge in Norway. Since 2015 he has served as Chairman of the Board at HØIBERG.